Biondo Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$8.55M |
| 2 |
IBM
IBM
|
+$6.92M |
| 3 |
Costco
COST
|
+$6.52M |
| 4 |
Transocean
RIG
|
+$704K |
| 5 |
Duke Energy
DUK
|
+$564K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$4.69M |
| 2 |
VF Corp
VFC
|
+$2.44M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$1.3M |
| 4 |
NVIDIA
NVDA
|
+$609K |
| 5 |
Adobe
ADBE
|
+$481K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.46% |
| 2 | Technology | 26.25% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Financials | 8.28% |
| 5 | Energy | 6.3% |
Similar funds
Biondo Investment Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Biondo Investment Advisors held 83 positions worth $531M, down 1.9% from $541M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Biondo Investment Advisors deployed $23.2M of net new capital in Q3 2023, opening 8 new positions and adding to 54 existing holdings. Its largest new stake was Eli Lilly: 16,599 shares worth $8.92M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $609K trimmed.
- Biondo Investment Advisors's largest Q3 2023 buy was Eli Lilly: 16,599 shares worth $8.92M.
- Biondo Investment Advisors added most to Duke Energy in Q3 2023, an estimated $564K increase.
- Biondo Investment Advisors's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $609K.
- Biondo Investment Advisors fully exited 3M in Q3 2023, selling an estimated $4.69M.
- Biondo Investment Advisors's ten largest holdings make up 47% of its $531M portfolio in Q3 2023.
- Biondo Investment Advisors opened 8 new positions and closed 5 in Q3 2023.
- Biondo Investment Advisors's portfolio value fell 1.9% quarter-over-quarter to $531M.
Based on Biondo Investment Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.